Insight journal - Dealtalk

Pfizer is in talks to acquire Actavis

Posted on 24 September 2014

Tags: , ,

Pfizer Inc. has approached Actavis with a possibility to acquire the company.

The companies aren’t in formal talks, said unnamed sources, with no offer on the table yet.

The news comes on a day rife with Wall Street downward pressure on biotech stocks, after U.S. Treasury Secretary Jacob Lew outlined new rules late Monday to dissuade domestic companies from so-called inversion, or using mergers and acquisitions as a way to move their headquarters to friendlier tax climates abroad. 

Pfizer was rebuffed in a similar effort last May in $114 billion bid for AstraZeneca, which would have allowed it to move its tax domicile to the United Kingdom. 

Parsippany, New Jersey-based Actavis would be an ideal inversion target for Pfizer because it snapped up its own Irish tax address last year when it acquired pharmaceutical Warner Chilcott Plc

For further deal information visit Current Agreements (subscription required)

Related

Browse: Complete Current Partnering report catalogue

View: Partnering Scorecard in CP Insight– view top life science partnering deals by value

View: DealMetrics in CP Insight – the latest deal trend infographics for life science deal making

View: CP Insight’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: CP Insight’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply